Neuromuscular disorders in the intensive care unit

Area of Science:

• Critical care medicine
• Neurology
• Immunology

Background:

• Neuromuscular disorders present diagnostic challenges in the intensive care unit (ICU).
• These disorders are broadly classified into those leading to ICU admission and those acquired during ICU stay.
• Understanding their pathogenesis is crucial for effective management.

Purpose of the Study:

• To categorize neuromuscular disorders relevant to ICU settings.
• To discuss immune-mediated neuromuscular diseases requiring ICU admission.
• To review common causes of ICU-acquired muscle weakness.

Main Methods:

• Literature review of neuromuscular disorders in the ICU.
• Focus on Guillain-Barré syndrome, myasthenia gravis, and dermatomyositis/polymyositis.
• Examination of critical care polyneuropathy and ICU-acquired myopathy.

Main Results:

• Guillain-Barré syndrome, myasthenia gravis, and dermatomyositis/polymyositis are immune-mediated disorders leading to ICU admission.
• Critical care polyneuropathy and ICU-acquired myopathy are primary causes of severe muscle weakness developed in the ICU.
• These acquired conditions often occur together, complicating patient recovery.

Conclusions:

• Neuromuscular disorders in the ICU require careful differentiation between pre-existing and acquired conditions.
• Immune-mediated disorders and ICU-acquired myopathies/polyneuropathies represent key challenges in critical care neurology.
• Accurate diagnosis and management strategies are essential for improving outcomes in critically ill patients with neuromuscular compromise.